journal article·2024-12-31Open access

Antibacterial potential of Euphorbia canariensis against Pseudomonas aeruginosa bacteria causing respiratory tract infections

Badriyah Alotaibi, Engy Elekhnawy, Thanaa A. El-Masry, Asmaa Saleh, Manal E. Alosaimi, Khalid Nijr Alotaibi, Walaa A. Negm

Abstract

The widespread dissemination of bacterial resistance has led to great attention being paid to finding substitutes for traditionally used antibiotics. Plants are rich in various phytochemicals that could be used as antibacterial therapies. Here, we elucidate the phytochemical profile of Euphorbia canariensis ethanol extract (EMEE) and then elucidate the antibacterial potential of ECEE against Pseudomonas aeruginosa clinical isolates. ECEE showed minimum inhibitory concentrations ranging from 128 to 512 µg/mL. The impact of ECEE on the biofilm-forming ability of the tested isolates was elucidated using crystal violet assay and qRT-PCR to study its effect on the gene expression level. ECEE exhibited antibiofilm potential, which resulted in a downregulation of the expression of the biofilm genes (algD, pelF, and pslD) in 39.13% of the tested isolates. The antibacterial potential of ECEE was studied in vivo using a lung infection model in mice. A remarkable improvement was observed in the ECEE-treated group, as revealed by the histological and immunohistochemical studies. Also, ELISA showed a noticeable decrease in the oxidative stress markers (nitric oxide and malondialdehyde). The gene expression of the proinflammatory marker (interleukin-6) was downregulated, while the anti-inflammatory biomarker was upregulated (interleukin-10). Thus, clinical trials should be performed soon to explore the potential antibacterial activity of ECEE, which could help in our battle against resistant pathogenic bacteria.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Bioactive Natural Diterpenoids Research · Essential Oils and Antimicrobial Activity · Plant-based Medicinal Research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Pharmaceutical Sciences, College of Pharmacy, Princess Nourah bint Abdulrahman University, Riyadh 84428, Saudi Arabia

Pharmaceutical Microbiology Department, Faculty of Pharmacy, Tanta University, Tanta, Egypt

Department of Pharmacology and Toxicology, Faculty of Pharmacy, Tanta University, Tanta, Egypt

Department of Basic Health Sciences, College of Medicine, Princess Nourah bint Abdulrahman University, Riyadh 84428, Saudi Arabia

Health Services Directorate, Ministry of Defense, Saudi Arabia

Department of Pharmacognosy, Faculty of Pharmacy, Tanta University, Tanta

Funding

Deanship of Scientific Research at Princess Nourah bint Abdulrahman University

References (40)

Show source-provided references
1. 10.1038/s41392-022-01056-110.1038/s41392-022-01056-1 ↗
2. 10.3390/pathogens1103030010.3390/pathogens11030300 ↗
3. 10.1016/S0140-6736(21)02724-010.1016/S0140-6736(21)02724-0 ↗
4. 10.1007/s40121-022-00591-210.1007/s40121-022-00591-2 ↗
5. 10.3390/w1212331310.3390/w12123313 ↗
6. 10.1016/j.sajb.2021.09.02610.1016/j.sajb.2021.09.026 ↗
7. 10.1016/j.fct.2020.11164210.1016/j.fct.2020.111642 ↗
8. 10.1016/j.jep.2022.11557410.1016/j.jep.2022.115574 ↗
9. 10.1016/j.phytochem.2021.11284610.1016/j.phytochem.2021.112846 ↗
10. 10.1016/j.phytochem.2006.06.03010.1016/j.phytochem.2006.06.030 ↗
11. 10.1155/2022/997108510.1155/2022/9971085 ↗
12. 10.2174/156802662266622071314343610.2174/1568026622666220713143436 ↗
13. 10.1111/j.2042-7158.1998.tb06182.x10.1111/j.2042-7158.1998.tb06182.x ↗
14. 10.3390/microorganisms910204110.3390/microorganisms9102041 ↗
15. 10.3389/fmicb.2018.0163910.3389/fmicb.2018.01639 ↗
16. 10.1016/j.sjbs.2017.02.00410.1016/j.sjbs.2017.02.004 ↗
17. 10.1016/j.sjbs.2020.08.01510.1016/j.sjbs.2020.08.015 ↗
18. 10.3390/metabo1101001510.3390/metabo11010015 ↗
19. 10.1371/journal.pone.016462210.1371/journal.pone.0164622 ↗
20. 10.1007/978-81-322-2680-2_410.1007/978-81-322-2680-2_4 ↗
21. 10.1038/s41392-022-00907-110.1038/s41392-022-00907-1 ↗
22. 10.3389/fimmu.2014.0007110.3389/fimmu.2014.00071 ↗
23. 10.1038/nri.2016.14710.1038/nri.2016.147 ↗
24. 10.1186/s12985-016-0528-010.1186/s12985-016-0528-0 ↗
25. 10.3389/fphys.2020.0069410.3389/fphys.2020.00694 ↗
26. 10.3390/ijms2023600810.3390/ijms20236008 ↗
27. 10.1016/j.immuni.2019.03.02010.1016/j.immuni.2019.03.020 ↗
28. 10.3390/molecules2704132910.3390/molecules27041329 ↗
29. 10.1080/10717544.2022.208372510.1080/10717544.2022.2083725 ↗
30. 10.1007/s42770-021-00485-410.1007/s42770-021-00485-4 ↗
31. 10.3390/antibiotics1007085910.3390/antibiotics10070859 ↗
32. 10.3390/antibiotics1108099310.3390/antibiotics11080993 ↗
33. 10.3390/molecules2722784110.3390/molecules27227841 ↗
34. 10.1007/s10787-022-01078-910.1007/s10787-022-01078-9 ↗
35. 10.1006/meth.2001.126210.1006/meth.2001.1262 ↗
36. 10.3390/ph1509104310.3390/ph15091043 ↗
37. 10.3390/jof810100510.3390/jof8101005 ↗
38. 10.3390/ph1511136110.3390/ph15111361 ↗
39. 10.1590/s0102-86502020005000000610.1590/s0102-865020200050000006 ↗
40. 10.1007/s10787-022-01070-310.1007/s10787-022-01070-3 ↗